ロード中...
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
The use of natalizumab for highly active relapsing-remitting multiple sclerosis (MS) is influenced by the occurrence of progressive multifocal leukoencephalopathy (PML). Through measurement of the anti-JCV antibody index, and in combination with the presence or absence of other known risk factors, i...
保存先:
| 出版年: | J Neurol Neurosurg Psychiatry |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4752634/ https://ncbi.nlm.nih.gov/pubmed/26492930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|